Table 1.
PATIENT CHARACTERISTICS | Adolescents with Metabolic Syndromea (N=1607634) (%) |
Adolescents without Metabolic Syndromea (N= 45045616) (%) |
P value |
---|---|---|---|
dAGE Quartile (U/kcal) | <.0001 | ||
Median (IQR) | 5.18 (3.32–7.04) | 4.85 (4.59–5.10) | |
≤2.73 | 395463 (24.6) | 11423568 (25.36) | |
2.74 – 4.98 | 370242 (23.03) | 11959619 (26.55) | |
4.99 – 8.68 | 310327 (19.3) | 12509168 (27.77) | |
>8.68 | 531602 (33.07) | 9153261 (20.32) | |
Race (%) | <.0001 | ||
White | 1159894 (72.15) | 29581937 (65.64) | |
Black | 111733 (6.95) | 6557434 (14.57) | |
Hispanic | 298768 (18.58) | 6348625 (14.11) | |
Other | 37239 (2.32) | 2557620 (5.68) | |
Gender (%) | <.0001 | ||
Male | 695952 (43.29) | 21315585 (47.32) | |
Female | 911682 (56.71) | 23730031 (52.68) | |
Family Income (USD) | <.0001 | ||
$0 - $34,999 | 593429 (37.93) | 17063279 (37.88) | |
$35,000 - $44,999 | 114435 (7.31) | 4252306 (9.44) | |
$45,000 - $64,999 | 339015 (21.67) | 6937024 (15.4) | |
>$65,000 | 517541 (33.08) | 16793007 (37.28) |
Abbreviation: dAGE, dietary Advanced Glycation End Products
Data are presented as number (percentage) of patients unless otherwise indicated